title: Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment.
abstract: Kaposi sarcoma associated herpesvirus (KSHV), a γ2-herpesvirus, also known as human herpesvirus-8, is the etiologic agent of three virally associated tumors: Kaposi sarcoma, a plasmablastic form of multicentric Castleman disease (KSHV-MCD), and primary effusion lymphoma. These malignancies are predominantly seen in people with acquired immunodeficiencies, including acquired immunodeficiency syndrome and iatrogenic immunosuppression in the setting of organ transplantation, but can also develop in the elderly. Kaposi sarcoma (KS) is most frequent in regions with high KSHV seroprevalence, such as sub-Saharan Africa and some Mediterranean countries. In the era of combination antiviral therapy, inflammatory manifestations associated with KSHV-infection, including KSHV-MCD, a recently described KSHV-associated inflammatory cytokine syndrome and KS immune reconstitution syndrome also are increasingly appreciated. Our understanding of viral and immune mechanisms of oncogenesis continues to expand and lead to improved molecular diagnostics, as well as novel therapeutic strategies that employ immune modulatory agents, manipulations of the tumor microenvironment, virus-activated cytotoxic therapy, or agents that target interactions between specific virus-host cell signaling pathways. This review focuses on the epidemiology and advances in molecular and clinical research that reflects the current understanding of viral oncogenesis, clinical manifestations, and therapeutics for KSHV-associated tumors.
authors.affiliation: HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, Bethesda, MD.
authors.forename: Manisha
authors.initials: M
authors.lastname: Bhutani
authors.affiliation: HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, Bethesda, MD.
authors.forename: Mark N
authors.initials: MN
authors.lastname: Polizzotto
authors.affiliation: HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, Bethesda, MD.
authors.forename: Thomas S
authors.initials: TS
authors.lastname: Uldrick
authors.affiliation: HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, Bethesda, MD. Electronic address: Robert.Yarchoan@nih.gov.
authors.forename: Robert
authors.initials: R
authors.lastname: Yarchoan
mesh_terms: D006566:Herpesviridae Infections / Q000150:complications* / Q000453:epidemiology*; D019288:Herpesvirus 8, Human; D006801:Humans; D009369:Neoplasms / Q000628:therapy / Q000821:virology*; D016036:Seroepidemiologic Studies
references.citation: N Engl J Med. 1999 Apr 8;340(14):1063-70
references.pmid: 10194235
references.citation: Science. 1999 Apr 23;284(5414):641-4
references.pmid: 10213686
references.citation: Blood. 1999 Jun 15;93(12):4034-43
references.pmid: 10361100
references.citation: N Engl J Med. 1999 Jun 17;340(24):1863-71
references.pmid: 10369849
references.citation: Oncogene. 1999 Oct 14;18(42):5738-46
references.pmid: 10523854
references.citation: AIDS. 1999 Oct 22;13(15):2105-11
references.pmid: 10546864
references.citation: J Clin Oncol. 1999 Jun;17(6):1876-83
references.pmid: 10561228
references.citation: Nature. 1999 Dec 23-30;402(6764):889-94
references.pmid: 10622254
references.citation: J Exp Med. 2000 Feb 7;191(3):445-54
references.pmid: 10662790
references.citation: Am J Epidemiol. 2000 Feb 1;151(3):213-24
references.pmid: 10670545
references.citation: J Clin Oncol. 2000 Apr;18(7):1550-7
references.pmid: 10735904
references.citation: J Infect Dis. 2000 May;181(5):1562-8
references.pmid: 10823754
references.citation: J Acquir Immune Defic Syndr. 2000 Apr 1;23(4):346-54
references.pmid: 10836758
references.citation: J Clin Oncol. 2000 Jul;18(13):2593-602
references.pmid: 10893291
references.citation: Blood. 2000 Aug 15;96(4):1599-601
references.pmid: 10942415
references.citation: Blood. 2000 Sep 15;96(6):2069-73
references.pmid: 10979949
references.citation: Cancer Res. 2000 Sep 1;60(17):4873-80
references.pmid: 10987301
references.citation: Blood. 2000 Oct 1;96(7):2562-7
references.pmid: 11001912
references.citation: Nat Med. 2000 Oct;6(10):1121-7
references.pmid: 11017143
references.citation: N Engl J Med. 2000 Nov 9;343(19):1369-77
references.pmid: 11070101
references.citation: J Virol. 2001 Jan;75(1):429-38
references.pmid: 11119611
references.citation: J Virol. 2001 Jan;75(1):458-68
references.pmid: 11119614
references.citation: N Engl J Med. 2001 Mar 1;344(9):637-43
references.pmid: 11228278
references.citation: Blood. 2001 Apr 1;97(7):2130-6
references.pmid: 11264181
references.citation: Blood. 2001 Apr 15;97(8):2526-7
references.pmid: 11307774
references.citation: Blood. 2001 May 15;97(10):3244-50
references.pmid: 11342455
references.citation: J Immunol. 2001 Jul 1;167(1):505-13
references.pmid: 11418689
references.citation: J Clin Virol. 2002 Jan;23(3):119-48
references.pmid: 11595592
references.citation: Emerg Infect Dis. 2001 Sep-Oct;7(5):893-5
references.pmid: 11747707
references.citation: JAMA. 2002 Jan 9;287(2):221-5
references.pmid: 11779265
references.citation: J Immunol. 2002 Feb 1;168(3):1226-34
references.pmid: 11801659
references.citation: J Infect Dis. 2002 Apr 1;185(7):990-3
references.pmid: 11920325
references.citation: J Interferon Cytokine Res. 2002 Mar;22(3):295-303
references.pmid: 12034036
references.citation: Cancer. 2002 Jul 1;95(1):147-54
references.pmid: 12115328
references.citation: J Med Virol. 2002 Aug;67(4):542-8
references.pmid: 12116002
references.citation: J Clin Oncol. 2002 Aug 1;20(15):3236-41
references.pmid: 12149296
references.citation: AIDS. 2002 Oct 18;16(15):2073-8
references.pmid: 12370507
references.citation: Science. 2002 Nov 15;298(5597):1432-5
references.pmid: 12434062
references.citation: Blood. 2003 May 15;101(10):4115-21
references.pmid: 12531789
references.citation: Nat Med. 2003 Mar;9(3):300-6
references.pmid: 12592400
references.citation: Nat Med. 2003 May;9(5):554-61
references.pmid: 12692543
references.citation: Oncogene. 2003 May 29;22(22):3371-85
references.pmid: 12776188
references.citation: J Clin Oncol. 2003 Aug 1;21(15):2876-82
references.pmid: 12885804
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10399-404
references.pmid: 12925741
references.citation: J Natl Cancer Inst. 2003 Sep 3;95(17):1330-5
references.pmid: 12953087
references.citation: Lancet. 1992 Mar 14;339(8794):632-5
references.pmid: 1347337
references.citation: Radiology. 1992 Dec;185(3):777-81
references.pmid: 1438762
references.citation: J Cutan Pathol. 2004 Jan;31(1):26-34
references.pmid: 14675282
references.citation: J Exp Med. 2004 Apr 5;199(7):993-1003
references.pmid: 15067035
references.citation: J Pediatr. 2004 Apr;144(4):519-23
references.pmid: 15069403
references.citation: J Virol. 2004 Jun;78(12):6585-94
references.pmid: 15163750
references.citation: Nat Genet. 2004 Jul;36(7):683-5
references.pmid: 15220917
references.citation: J Infect Dis. 2004 Aug 1;190(3):484-8
references.pmid: 15243920
references.citation: Am J Surg Pathol. 2004 Nov;28(11):1401-16
references.pmid: 15489644
references.citation: Science. 2005 Feb 4;307(5710):739-41
references.pmid: 15692053
references.citation: J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):474-9
references.pmid: 15764964
references.citation: N Engl J Med. 2005 Mar 31;352(13):1317-23
references.pmid: 15800227
references.citation: Blood. 2005 Aug 15;106(4):1203-6
references.pmid: 15840696
references.citation: J Clin Oncol. 2005 Jul 1;23(19):4372-80
references.pmid: 15994147
references.citation: J Virol. 2005 Jul;79(14):9301-5
references.pmid: 15994824
references.citation: Antivir Ther. 2005;10(6):745-51
references.pmid: 16218174
references.citation: Blood. 2006 Apr 15;107(8):3295-302
references.pmid: 16380446
references.citation: J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):149-53
references.pmid: 16394845
references.citation: J Clin Oncol. 2006 Mar 20;24(9):1389-94
references.pmid: 16549833
references.citation: Br J Cancer. 2006 Apr 10;94(7):1000-6
references.pmid: 16570046
references.citation: Eur J Pediatr. 2006 Jul;165(7):453-7
references.pmid: 16602009
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):926-34
references.pmid: 16702372
references.citation: AIDS. 2006 Aug 1;20(12):1645-54
references.pmid: 16868446
references.citation: Cancer Cell. 2006 Aug;10(2):133-43
references.pmid: 16904612
references.citation: J Infect Dis. 2006 Oct 15;194(8):1078-88
references.pmid: 16991082
references.citation: Cancer. 2006 Nov 1;107(9):2282-90
references.pmid: 16998933
references.citation: N Engl J Med. 2006 Sep 28;355(13):1331-8
references.pmid: 17005950
references.citation: Blood. 2007 Feb 15;109(4):1550-8
references.pmid: 17047149
references.citation: J Virol. 2007 Mar;81(5):2401-17
references.pmid: 17151125
references.citation: J Infect Dis. 2007 Jan 1;195(1):30-6
references.pmid: 17152006
references.citation: Oncologist. 2007 Jan;12(1):114-23
references.pmid: 17227906
references.citation: J Natl Cancer Inst. 2007 Jun 20;99(12):962-72
references.pmid: 17565153
references.citation: J Infect Dis. 2007 Jul 15;196(2):199-207
references.pmid: 17570106
references.citation: Cancer Res. 2007 Jul 15;67(14):7003-10
references.pmid: 17638913
references.citation: J Clin Oncol. 2007 Aug 1;25(22):3350-6
references.pmid: 17664482
references.citation: Blood. 2008 Jan 1;111(1):320-7
references.pmid: 17890449
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16287-92
references.pmid: 17909182
references.citation: Cell Biol Int. 2008 Jan;32(1):157-62
references.pmid: 17950633
references.citation: BMC Infect Dis. 2007 Dec 05;7:143
references.pmid: 18053246
references.citation: Transpl Infect Dis. 2008 Jun;10(3):221-6
references.pmid: 18086278
references.citation: Ann Intern Med. 2007 Dec 18;147(12):836-9
references.pmid: 18087054
references.citation: AIDS. 2008 Feb 19;22(4):519-26
references.pmid: 18301065
references.citation: J Virol. 2008 May;82(10):4793-806
references.pmid: 18337571
references.citation: Cancer Res. 2008 Mar 15;68(6):1751-9
references.pmid: 18339855
references.citation: AIDS Rev. 2008 Jan-Mar;10(1):25-35
references.pmid: 18385778
references.citation: Am J Surg Pathol. 2008 Jul;32(7):1006-12
references.pmid: 18469709
references.citation: J Virol. 2009 Jan;83(2):722-33
references.pmid: 18987143
references.citation: J Virol. 2009 Mar;83(5):2140-53
references.pmid: 19091861
references.citation: Ann Oncol. 2009 Apr;20(4):775-9
references.pmid: 19179554
references.citation: Clin Vaccine Immunol. 2009 May;16(5):621-7
references.pmid: 19261774
references.citation: Lancet Oncol. 2009 Apr;10(4):321-2
references.pmid: 19350698
references.citation: Clin Infect Dis. 2009 Jun 1;48(11):1601-8
references.pmid: 19400749
references.citation: J Infect Dis. 2009 Aug 1;200(3):430-8
references.pmid: 19534596
references.citation: Leukemia. 2009 Oct;23(10):1867-74
references.pmid: 19554030
references.citation: Lancet. 1990 Jan 20;335(8682):123-8
references.pmid: 1967430
references.citation: Am J Transplant. 2009 Nov;9(11):2580-6
references.pmid: 19775317
references.citation: Nat Cell Biol. 2009 Nov;11(11):1355-62
references.pmid: 19838173
references.citation: Clin Exp Dermatol. 2010 Jan;35(1):68-72
references.pmid: 19874352
references.citation: J Leukoc Biol. 2010 Jan;87(1):25-34
references.pmid: 20052801
references.citation: J Immunol Methods. 2010 Apr 30;356(1-2):39-46
references.pmid: 20211626
references.citation: Virol J. 2010 Mar 17;7:62
references.pmid: 20236530
references.citation: PLoS Pathog. 2010 Mar 19;6(3):e1000818
references.pmid: 20333249
references.citation: Cancer. 2010 Aug 15;116(16):3969-77
references.pmid: 20564162
references.citation: Clin Infect Dis. 2010 Aug 1;51(3):350-8
references.pmid: 20583924
references.citation: J Pathol. 2010 Oct;222(2):166-79
references.pmid: 20690162
references.citation: PLoS Pathog. 2010 Aug 12;6(8):e1001046
references.pmid: 20730087
references.citation: J Exp Med. 2010 Oct 25;207(11):2307-12
references.pmid: 20876309
references.citation: Cancer. 2011 Mar 1;117(5):1089-96
references.pmid: 20960504
references.citation: J Virol. 2011 Jan;85(2):715-24
references.pmid: 21068240
references.citation: J Virol. 2011 May;85(9):4530-7
references.pmid: 21345951
references.citation: J Natl Cancer Inst. 2011 May 4;103(9):753-62
references.pmid: 21483021
references.citation: Blood. 2011 Jun 30;117(26):6977-86
references.pmid: 21487108
references.citation: Am J Transplant. 2011 Dec;11(12):2715-23
references.pmid: 21966899
references.citation: JAMA. 2011 Nov 2;306(17):1891-901
references.pmid: 22045767
references.citation: J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):447-54
references.pmid: 22067664
references.citation: Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2551-9
references.pmid: 22109347
references.citation: Blood. 2012 Mar 8;119(10):2228-33
references.pmid: 22223822
references.citation: J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):150-7
references.pmid: 22395672
references.citation: Front Microbiol. 2012 Mar 02;3:73
references.pmid: 22403576
references.citation: J Clin Oncol. 2012 May 1;30(13):1476-83
references.pmid: 22430271
references.citation: J Infect Dis. 2012 Jun;205(11):1665-76
references.pmid: 22448005
references.citation: Blood. 2012 May 31;119(22):5173-81
references.pmid: 22490805
references.citation: Transfus Med Rev. 2012 Oct;26(4):281-304, 304.e1-2
references.pmid: 22633182
references.citation: Curr Opin Oncol. 2012 Sep;24(5):495-505
references.pmid: 22729151
references.citation: J Virol. 2012 Nov;86(21):11663-74
references.pmid: 22896623
references.citation: Am J Transplant. 2013 Jan;13(1):207-13
references.pmid: 23057808
references.citation: Am J Transplant. 2013 Jan;13(1):214-21
references.pmid: 23057816
references.citation: Leuk Lymphoma. 2013 Jul;54(7):1560-3
references.pmid: 23228024
references.citation: J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):228-33
references.pmid: 23403859
references.citation: AIDS. 2013 Jul 17;27(11):1735-42
references.pmid: 23435301
references.citation: Curr Opin Virol. 2013 Jun;3(3):266-75
references.pmid: 23743127
references.citation: PLoS One. 2013 Jun 05;8(6):e64392
references.pmid: 23755122
references.citation: J Virol. 2013 Sep;87(17):9398-410
references.pmid: 23785197
references.citation: J Immunol. 2013 Aug 1;191(3):1476-85
references.pmid: 23804715
references.citation: Blood. 2013 Aug 15;122(7):1233-42
references.pmid: 23838350
references.citation: J Exp Med. 2013 Aug 26;210(9):1743-59
references.pmid: 23897980
references.citation: J Virol. 2013 Oct;87(19):10816-27
references.pmid: 23903842
references.citation: PLoS Pathog. 2013;9(9):e1003584
references.pmid: 24039573
references.citation: Blood. 2013 Dec 19;122(26):4189-98
references.pmid: 24174627
references.citation: J Virol. 2014 Jan;88(2):1281-92
references.pmid: 24227836
references.citation: J Clin Oncol. 2014 Feb 10;32(5):402-8
references.pmid: 24378417
references.citation: J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):e80-2
references.pmid: 24442228
references.citation: J Pediatr Hematol Oncol. 2014 Mar;36(2):111-7
references.pmid: 24552745
references.citation: Int J Cancer. 2014 Jul 15;135(2):432-9
references.pmid: 24615279
references.citation: PLoS Pathog. 2014 Mar 27;10(3):e1004046
references.pmid: 24675986
references.citation: J Clin Oncol. 1989 Sep;7(9):1201-7
references.pmid: 2671281
references.citation: Am J Med. 1984 Mar;76(3):493-500
references.pmid: 6322585
references.citation: MMWR Morb Mortal Wkly Rep. 1981 Jul 3;30(25):305-8
references.pmid: 6789108
references.citation: Cancer. 1978 Dec;42(6):2626-30
references.pmid: 728865
references.citation: Blood. 1995 Aug 15;86(4):1276-80
references.pmid: 7632932
references.citation: Lancet. 1995 Sep 23;346(8978):799-802
references.pmid: 7674745
references.citation: N Engl J Med. 1995 May 4;332(18):1181-5
references.pmid: 7700310
references.citation: N Engl J Med. 1995 May 4;332(18):1186-91
references.pmid: 7700311
references.citation: Science. 1995 Apr 28;268(5210):582-3
references.pmid: 7725108
references.citation: Lancet. 1995 Mar 25;345(8952):761-2
references.pmid: 7891488
references.citation: Science. 1994 Dec 16;266(5192):1865-9
references.pmid: 7997879
references.citation: Arch Intern Med. 1996 Jan 22;156(2):202-4
references.pmid: 8546554
references.citation: N Engl J Med. 1996 May 2;334(18):1168-72
references.pmid: 8602183
references.citation: N Engl J Med. 1996 Jul 25;335(4):233-41
references.pmid: 8657239
references.citation: Blood. 1996 Jul 15;88(2):645-56
references.pmid: 8695812
references.citation: Nat Med. 1996 Aug;2(8):918-24
references.pmid: 8705863
references.citation: Nat Med. 1996 Aug;2(8):925-8
references.pmid: 8705864
references.citation: J Clin Oncol. 1996 Aug;14(8):2353-64
references.pmid: 8708728
references.citation: Lancet. 1996 Oct 26;348(9035):1133-8
references.pmid: 8888167
references.citation: J Virol. 1996 Nov;70(11):8218-23
references.pmid: 8892957
references.citation: AIDS. 1996 Jan;10(1):61-7
references.pmid: 8924253
references.citation: Science. 1996 Dec 6;274(5293):1739-44
references.pmid: 8939871
references.citation: J Virol. 1997 Jan;71(1):715-9
references.pmid: 8985403
references.citation: Nature. 1997 Jan 23;385(6614):347-50
references.pmid: 9002520
references.citation: Nature. 1997 Apr 3;386(6624):517-21
references.pmid: 9087414
references.citation: Am J Epidemiol. 1997 Apr 15;145(8):673-9
references.pmid: 9125993
references.citation: J Clin Invest. 1997 May 1;99(9):2082-6
references.pmid: 9151779
references.citation: J Virol. 1997 Jun;71(6):4193-8
references.pmid: 9151805
references.citation: J Clin Oncol. 1997 May;15(5):2118-24
references.pmid: 9164226
references.citation: J Biol Chem. 1997 Aug 1;272(31):19625-31
references.pmid: 9235971
references.citation: J Clin Oncol. 1997 Sep;15(9):3085-92
references.pmid: 9294471
references.citation: Science. 1997 Oct 10;278(5336):290-4
references.pmid: 9323208
references.citation: Oncogene. 1997 Oct 16;15(16):1979-85
references.pmid: 9365244
references.citation: Nature. 1998 Jan 1;391(6662):86-9
references.pmid: 9422510
references.citation: J Virol. 1998 Feb;72(2):1005-12
references.pmid: 9444993
references.citation: J Clin Oncol. 1998 Feb;16(2):683-91
references.pmid: 9469358
references.citation: J Natl Cancer Inst. 1998 Mar 4;90(5):395-7
references.pmid: 9498490
references.citation: J Clin Oncol. 1998 Mar;16(3):1112-21
references.pmid: 9508198
references.citation: N Engl J Med. 1998 Apr 2;338(14):948-54
references.pmid: 9521982
references.citation: J Virol. 1998 Jun;72(6):4980-8
references.pmid: 9573267
references.citation: J Clin Oncol. 1998 May;16(5):1736-42
references.pmid: 9586886
references.citation: J Clin Oncol. 1998 Jul;16(7):2445-51
references.pmid: 9667262
references.citation: Nature. 1998 Aug 6;394(6693):588-92
references.pmid: 9707121
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10866-71
references.pmid: 9724796
references.citation: N Engl J Med. 1998 Nov 5;339(19):1358-63
references.pmid: 9801396
references.citation: Br J Cancer. 1998 Dec;78(11):1521-8
references.pmid: 9836488
references.citation: Int J STD AIDS. 1998 Dec;9(12):751-5
references.pmid: 9874123
references.citation: AIDS. 1998 Dec 24;12(18):2481-8
references.pmid: 9875587
references.citation: EMBO J. 1999 Feb 1;18(3):654-63
references.pmid: 9927425